Literature DB >> 20413862

Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention?

José A Luchsinger1.   

Abstract

This manuscript provides a comprehensive review of the epidemiologic evidence linking type 2 diabetes (T2D) and its precursor conditions, elevated adiposity and hyperinsulinemia, to dementia. The mechanisms relating these conditions to dementia may be vascular and non-vascular. Elevated adiposity in middle age is related to a higher risk of dementia but the data on this association in old age is conflicting. Several studies have shown that hyperinsulinemia, a consequence of higher adiposity and insulin resistance, is also related to a higher risk of dementia, including late onset Alzheimer's disease (LOAD). Studies have consistently shown a relation of T2D with higher dementia risk, but the associations are stronger for vascular dementia compared to LOAD. A large proportion of the world population may be at increased risk of dementia given the trends for increasing prevalence of overweight, obesity, hyperinsulinemia, and T2D. However, these associations may present a unique opportunity for prevention and treatment of dementia. There are several known modalities that are effective in the prevention and T2D and the reduction of hyperinsulinemia including lifestyle interventions, metformin, thiazolideniodones, and acarbose. Several studies in the prevention and treatment of T2D are currently measuring cognitive outcomes and will provide information on whether T2D treatment and prevention can prevent cognitive decline and dementia.

Entities:  

Mesh:

Year:  2010        PMID: 20413862     DOI: 10.3233/JAD-2010-091687

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  41 in total

Review 1.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

Review 2.  GluT4: A central player in hippocampal memory and brain insulin resistance.

Authors:  Ewan C McNay; Jiah Pearson-Leary
Journal:  Exp Neurol       Date:  2019-10-12       Impact factor: 5.330

3.  Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats.

Authors:  Bhupesh Sharma; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-01-12       Impact factor: 4.530

4.  Dementia and Alzheimer's disease: a new direction.The 2010 Jay L. Foster Memorial Lecture.

Authors:  Lewis H Kuller; Oscar L Lopez
Journal:  Alzheimers Dement       Date:  2011-09       Impact factor: 21.566

5.  An inducible model of human amylin overexpression reveals diverse transcriptional changes.

Authors:  Yoseph Aldras; Sanghamitra Singh; Katrin Bode; Diti Chatterjee Bhowmick; Aleksandar Jeremic; Damien M O'Halloran
Journal:  Neurosci Lett       Date:  2019-04-08       Impact factor: 3.046

6.  Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in China.

Authors:  Qing-Hua Wang; Xin Wang; Xian-Le Bu; Yan Lian; Yang Xiang; Hong-Bo Luo; Hai-Qiang Zou; Jie Pu; Zhong-He Zhou; Xiao-Ping Cui; Qing-Song Wang; Xiang-Qun Shi; Wei Han; Qiang Wu; Hui-Sheng Chen; Hang Lin; Chang-Yue Gao; Li-Li Zhang; Zhi-Qiang Xu; Meng Zhang; Hua-Dong Zhou; Yan-Jiang Wang
Journal:  Neurosci Bull       Date:  2017-11-13       Impact factor: 5.203

Review 7.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study.

Authors:  Stefan Walter; Jessica R Marden; Laura D Kubzansky; Elizabeth R Mayeda; Paul K Crane; Shun-Chiao Chang; Marilyn Cornelis; David H Rehkopf; Shubhabrata Mukherjee; M Maria Glymour
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

9.  Adiposity and cognitive decline in the cardiovascular health study.

Authors:  José A Luchsinger; Mary L Biggs; Jorge R Kizer; Joshua Barzilay; Annette Fitzpatrick; Anne Newman; William T Longstreth; Oscar Lopez; David Siscovick; Lewis Kuller
Journal:  Neuroepidemiology       Date:  2013-02-23       Impact factor: 3.282

Review 10.  Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

Authors:  Suzanne M de la Monte
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-28       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.